Joshua Kaufman, MD, of CDPHP, discusses the significance of long-acting injectables (LAIs) in improving adherence, reducing the risk of relapse, and preventing hospitalizations. Joshua Kaufman, MD, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results